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Abstract 
A common concern regarding clinical trials evaluating treatments for depression is findings may 
not generalize to the population of interest due to the use of restrictive exclusion criteria. To 
evaluate the exclusion criteria used in such research, we examined a large body of reports of 
randomized controlled trials of psychotherapies for adult depression. We analyzed the rates of 
four major types of exclusions: suicide related exclusions, an exclusion for when depression is 
not deemed the primary or principal diagnosis, exclusions due to comorbid diagnoses, and 
exclusions related to substance use. Data were drawn from a compilation of randomized 
controlled and comparative trials of psychotherapy on adult depression assembled by Professor 
Pim Cuijpers. Our analyses include 332 of the original 358 studies, as we excluded prevention 
studies, meta analyses, reports not available in English, and those that we could not access. Two 
raters coded each of these studies. Reliability for the raters’ judgements ranged from moderate to 
high (Cohen’s kappa of .52 to 1.00). Of the studies examined, 42% used a suicide related 
exclusion, 72% excluded for the presence of specific comorbid disorders, 63% excluded 
participants who did not have depression as a primary / principal diagnosis, and 52% excluded 
participants on the basis of substance use. Within those broader categories, the following specific 
exclusions were found to be used increasingly over time: use of a measure for operationalizing a 
suicide-related exclusion, self-harm, any bipolar spectrum disorder, current alcohol abuse, and 
current drug abuse. In contrast, four exclusions were found to be used with reduced frequency 
over time: requiring hospitalization, antisocial personality disorder (ASPD), having no disorder-
based exclusions, and past alcohol abuse. These changes show that exclusion criteria have 
changed over the course of the last fifty years. To our knowledge, these changes have been 
unidentified to date. While researchers may disagree about what exclusion criteria should be 
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used in trials, specific differences have gotten little attention in the literature, perhaps preventing 
a consensus about under what circumstances various criteria should be used. We hope our work 
can help to prompt greater consideration of the use of specific exclusion criteria.  
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A Closer Look at Exclusion Criteria in Randomized Controlled 
Psychotherapy Trials for Adult Depression 
It is widely recognized that when designing an experiment there are often compromises 
between external and internal validity, and clinical trial investigators have generally tended to 
favor the latter. High levels of internal validity mean that the experiment properly manipulated 
its variables and allows for valid causal inferences, while high levels of external validity mean 
that the results of the study are likely to generalize to the population of interest. A number of 
researchers have suggested that the goal of achieving higher internal validity has encouraged 
researchers to use overly restrictive inclusion / exclusion criteria (see Westen, Novotny, & 
Thompson-Brenner, 2004). Often researchers “associate restrictive exclusion / inclusion criteria 
with lower external validity and higher internal validity” (Lorenzo-Luaces, Zimmerman, & 
Cuijpers, 2018), causing them to exclude participants that may belong to the population of 
interest in order to avoid confounding variables.  
For a disorder such as depression that is common, heterogenous and often comorbid with 
other conditions, this view appears especially relevant. Depression is commonly comorbid with 
other disorders. For example, Brière, Rohde, Seeley, Klein, and Lewinsohn (2014) found that 
40% of participants with a lifetime history of major depressive disorder (MDD) had a history of 
alcohol use disorder (AUD) (and that 59% of those with a lifetime history of AUD had a history 
of MDD). Additionally, 27% of the individuals in the study with concurrent MDD and AUD 
were found to have had MDD first, perhaps suggesting that MDD was primary in this subset of 
cases (Brière, Rohde, Seeley, Klein, & Lewinsohn, 2014). Likewise, surveys have found that 
6.1% of individuals with MDD also experience drug abuse or dependence in their lifetime, and 
1.5% have in the last year (Grant, 1995). 
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Concerns surrounding the above findings have led some to question the external validity 
of randomized controlled trials (RCTs; see Westen, Novotny, & Thompson-Brenner, 2004) and 
to call for a shift away from treatment packages towards providing clinicians with individual 
empirically supported principles that they could integrate into treatments. Discussions of the 
limitations of exclusion criteria would benefit from a more precise characterization of what 
criteria have been and are being used in trials. In this thesis, we will examine exclusion criteria 
trends over a fifty-year span of clinical trials, including both RCTs (trials with a control group) 
and comparative efficacy studies (trials lacking a control group).  
Though restrictive exclusion criteria may be problematic for the generalizability of 
research on the population of those with depression, its exact effects are difficult to discern. 
Other research such as that by Lorenzo-Luaces, Zimmerman, and Cuijpers (2018) has shown that 
though there are issues with the inclusion / exclusion criteria in MDD research, these concerns 
might be greatest for trials of antidepressant medication. Lorenzo-Luaces, Zimmerman, and 
Cuijpers (2018) analyzed the differences in the use of inclusion / exclusion criteria between 
psychotherapy and antidepressant studies. They coded sixteen studies for their participant 
exclusion / inclusion criteria and found that psychotherapy studies tend to be more inclusive than 
antidepressant medication studies overall. Compared to psychotherapy studies, antidepressant 
medication trials tended to more often exclude for brief episodes, low symptom severity, and 
specific diagnoses other than depression. Both types of studies excluded for psychotic symptoms, 
substance abuse / dependence, and suicidality at equally high rates, with the most common 
exclusion for both being milder depressive symptoms. Insofar as problems related to inclusion / 
exclusion criteria differ across different treatment modalities, the quality of inferences from 
meta-analyses comparing across these studies is likely to be compromised.  
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Wiltsey, DeRubeis, Christoph, and Brody (2003) suggested that a high rate of exclusion 
is not in and of itself problematic for the generalizability of the clinical trial literature. They point 
out that patients who have constellations of problems that lead them to be excluded from one 
trial may still be eligible for another trial. Concerns about generalizability of the clinical trial 
literature are warranted if there are patients who have a clinical presentation that is unrepresented 
in the clinical trial literature. If so, such patients are understudied and results of clinical trials are 
not available to inform their care. In order to determine if individuals who were excluded from a 
clinical trial would be deemed ineligible from all clinical trials conducted at the time, Wiltsey 
and colleagues had raters evaluate 347 patients’ clinical charts from a managed care sample and 
rate on a 4-point Likert scale if each patient would qualify for an RCT for any of 10 
psychological disorders. Of patients with a diagnosis studied in the literature, 80% would have 
been eligible for one or more trials. However, 58% of the sample was composed of patients with 
diagnoses for which no trials existed, such as adjustment disorder. When a patient had a 
diagnosis that had been studied but was not eligible for any trial, they were often excluded on the 
basis of having low severity or substance abuse or dependence. This work suggests that a pattern 
of high exclusion rates from trials may not provide the information needed to assess the 
generalizability of the literature. Moreover, the specific findings suggest more specific areas to 
focus on to improve the extent to which the literature can more fully inform care for a wide 
variety of clients.  
Wiltsey, DeRubeis, Christoph, and Rothman built on their previous work in a follow-up 
study (2005) exploring the exclusion rates of RCTs specifically in MDD trials. They pulled 
records for potential participants excluded from MDD studies at the University of Pennsylvania 
between 1995 and 2001. They had graduate students analyze if the formerly excluded 
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participants would be eligible for any published studies evaluating treatments for MDD, panic 
disorder, generalized anxiety disorder (GAD), post-traumatic stress disorder (PTSD), alcohol 
dependence, substance dependence, bulimia, obsessive-compulsive disorder (OCD), social 
phobia, or schizophrenia. They found that among those excluded from previous studies 
participants with substance use disorders and social anxiety disorder were at increased risk for 
exclusion in all RCTs. Such analyses help to address the question of whether there are patients 
who are excluded not only from one trial, but have clinical problems that are excluded from all 
trials. Of course, all of this work is dependent upon clearly defined and well-measured inclusion 
and exclusion criteria. Whether researchers are clear about their criteria and how they are 
assessing these criteria is important to understand for that reason.  
Both the work of Lorenzo-Luaces and colleagues as well as Wiltsey and colleagues 
focused on carefully examining relatively small numbers of studies, and each acknowledged that 
broader analysis of the larger literature is needed. In light of this prior work, and in order to 
answer the questions surrounding how researchers assess inclusion / exclusion criteria and how 
the use of exclusion criteria may have changed over time within depression research, we sought 
to examine inclusion and exclusion criteria in a large collection of randomized trials. Through 
this research we will analyze the use of inclusion / exclusion criteria in trials of psychotherapies 
for adults with depression and how use of these criteria may have changed over time.  
We will examine four distinct areas of exclusion criteria within adult depression RCTs: 
suicide related exclusions, disorder exclusions, exclusions related to depression not being 
primary, and substance use exclusions. Additionally, we will evaluate the possibility that use of 
these criteria has changed over time. We expect to find a high rate of studies using substance use 
related exclusions. We also expect to see a decline in recent years based on previous researchers’ 
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recommendations that the literature be more inclusive of these participants. Similarly, we expect 
to find high rates of axis I disorder related exclusions with a decrease in their usage in more 
recent years. We expect to see a moderate use of exclusions related to depression not being 
primary and suicide related exclusions. We were also interested in exploring the extent to which 
investigators use clear measurement-based criteria for assessing these exclusions.  
Method 
Identification and Selection of Studies 
The data set used for this study comes from a compilation of randomized controlled and 
comparative trials of psychotherapy on adult depression created by Professor Pim Cuijpers from 
the University of Amsterdam. In total, the data set consists of 358 studies. The data set, and the 
criteria used in its creation can be accessed at http://www.evidencebasedpsychotherapies.org/. 
The studies included provide a list of all studies on adult depression conducted from 1975 
through January 2012 that were found using literature searches in the databases PubMed, 
Embase, PsycINFO, and the Cochrane Register of Controlled Trials. From this initial search 
Cuijpers excluded duplicates, trials on maintenance, collaborative care, and those that were not 
published in English, German, Spanish, or Dutch. Cuijpers and his team independently coded the 
following for each study: specific psychotherapy or pharmacotherapy provided, the control and 
experimental group(s) condition(s), the number of participants in each trial, and effect sizes 
associated with each of the studies.  
Our only exclusion criteria for studies beyond those laid out by Cuijpers was that they 
must be available in English, must be accessible, and could not be either a prevention study or a 
meta-analysis. Ultimately, eleven studies were excluded due to not being available in English, 
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eleven for being prevention studies, two for being meta-analyses, and two for being inaccessible. 
This resulted in the final set of 332 studies.  
Study Coding 
Two raters independently analyzed each study’s method section to assess its inclusion 
and exclusion criteria. Each study was coded for what were expected to be common exclusion 
and inclusion criteria along with additional inquiries about how some criteria were assessed. Less 
common exclusion / inclusion criteria were coded by selecting an ‘other’ option which would 
then allow for an open-ended response. To determine inter-rater reliability Cohen’s kappa scores 
were calculated for each individual variable within the exclusion criteria categories.  
We coded for use of the following exclusion criteria in each study: suicide related 
exclusions, depression not being the primary / principal diagnosis, exclusions due to comorbid 
diagnoses other than substance use disorders, and exclusions related to substance abuse. Other 
criteria not analyzed for this report were also coded. These included: requirement of a medical or 
psychiatric condition other than depression, any participant demographic requirements, journal 
of publication, date of publication, continent of experiment, and additional exclusions related to 
medical problems. If data were available, we also recorded what diagnostic tools, if any, were 
used to assess participants’ conditions.  
Suicide Related Exclusions 
 
The following options were available to the coders when answering if a study contained 
any suicide related exclusions: requiring a current / previous ideation, imminent suicide risk 
(without measure specified), require hospitalization, suicidal ideation (without measure 
specified), past history of suicidal ideation exclusion, self-harm, score above a threshold on a 
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suicide measure, plan, and not specified. Coders were allowed to select multiple options to 
characterize the use of multiple exclusion criteria.  
Use of suicide measures were coded to collect information on any measures used to 
assess suicidal risk as part of inclusion or exclusion criteria. In order for a study to be coded as 
including a suicide measure, its methods section had to mention that participants needed a 
specific score on a questionnaire to determine if they would be included in the study. Examples 
include the use of the Patient Health Questionnaire item 9, the suicide item on the Beck 
Depression Inventory II, and the Montgomery-Asberg Depression Rating Scale item 10.  
A study was coded as having an exclusion for the presence of suicidal ideation (without 
mesure specified) if within the methods section it mentioned participants being unable to have a 
suicidal ideation at the time of the study, but did not offer an operational definition of suicidal 
ideation. The same is true for the variable suicide risk (without mesure specified) in which the 
phrase suicide risk appeard in the methods section, but the phrase was never defined or 
opperationalized.  
Comorbid Disorder Exclusions 
An exclusion criterion was coded within the category of Comorbid Disorder Exclusions 
when a study’s methods section specified that individuals with a specific psychological disorder 
(other than disorders of substance use or abuse or eating disorders) would be excluded from 
participating in the study. Exclusions for physical ailments (e.g., cancer), neurocognitive 
disorders and organic mental disorders (e.g., dementia, Parkinson’s Disease), and eating 
disorders were coded separately and are not analyzed within this paper. When coding for 
disorder exclusions the coders were allowed to select multiple of the following options: 
ADD/ADHD, ASPD, any personality disorder, cluster A personality disorders, any form of 
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bipolar disorder, borderline personality disorder (BPD), axis I disorders, psychosis, schizotypal, 
schizoaffective, and none. Additional categories were created as needed over the course of the 
rating process.  
Depression Not Primary Exclusion 
 
Use of an exclusion criterion for depression not being the primary diagnosis was also 
coded. A diagnosis of depression was defined as either the study specifying that it required 
participants to have a diagnosis of depression or that a participant needed to meet research 
diagnostic criteria or criteria from the diagnostic and statistical manual of mental disorders.  
Substance Use Exclusions 
 
A substance use exclusion was coded when studies excluded for conditions defined by 
the consumption of alcohol or drugs. It was possible for a study to be coded as any of the 
following seven substance exclusions; none, current alcohol abuse, current drug abuse, past 
alcohol abuse, past drug abuse, alcohol abuse timeframe not specified, and drug abuse timeframe 
not specified. If a study stated that a participant was excluded due to substance dependence or 
abuse, the study was coded as both current alcohol and current drug abuse. Additionally, studies 
that required participants to have substance dependence were coded as none, as this was an 
inclusion rather than an exclusion criterion.  
Results 
Cohen’s Kappa  
Given the categorical nature of the ratings, Cohen’s kappa scores were calculated for 
each exclusion criteria category to assess inter-rater reliability. As shown in Table 1, the scores 
ranged from .66 to 1.00, indicating a moderate to strong level of inter-rater reliability.  
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Descriptive Statistics  
For suicide related exclusions, of the 332 total studies analyzed, 180 (54%) studies did 
not have any suicide related exclusion criteria. Three (1%) required participants to either have 
previously or currently have suicidal ideation in order to participate. Among the remaining 139 
studies with a suicide related exclusion, the most common suicide related exclusion was suicidal 
ideation with 88 studies (63%), followed by 56 studies that excluded for suicide risk (40%), 22 
that used a suicide measure based exclusion (16%), 14 that excluded due to having a suicide plan 
(10%), 10 that excluded for requiring hospitalization (7%), 3 that had a self-harm related 
exclusion (2%), and 18 that had history of suicide attempts and/or past ideation as an exclusion 
(13%). There was overlap among studies’ exclusion criteria with 44 studies using two exclusion 
criteria, and 7 using three or more.   
For disorder exclusions, of the 332 total studies analyzed, 99 (30%) did not exclude 
participants due to having another psychological disorder other than depression (this included 
psychological disorders other than substance use disorder or eating disorders). The remaining 
233 (70%) studies did have at least one such exclusion. The exclusions were: 163 studies 
excluded for experiencing or having a history of psychosis (49%), 135 studies excluded for any 
bipolar spectrum disorder (41%), 46 studies excluded for panic or other anxiety disorders (14%), 
39 studies excluded for ASPD (12%), 25 studies excluded for BPD (8%), 17 studies excluded for 
schizotypal personality disorder (5%), and 11 studies excluded for any personality disorder (3%).  
For depression as not primary exclusions, of the 332 total studies, 208 (63%) studies 
excluded participants for not having a primary diagnosis of MDD, with the 124 remaining 
studies (37%) allowing participants to have a primary diagnosis other than MDD, typically by 
not having criteria related to what diagnosis is primary. The 208 studies that excluded 
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participants for not having a primary diagnosis of MDD were broken down into four categories. 
The most common category was studies requiring participants to have a non-primary diagnosis 
of MDD (at 126, 38%), followed by studies listing multiple exclusions related to a lack of 
diagnosis or MDD not being primary/principal (at 40, 12%), directly stating that depression is 
not primary / principal (at 31, 9%), and exclusions relative to a specific diagnosis (e.g., only 
excluded participants if a specific disorder was primary over MDD)(at 30, 9%).  
Regarding substance use exclusions, 173 out of 332 total studies (52%) excluded 
participants for some form of substance abuse or dependence. These 173 studies were further 
broken down into the following categories: current alcohol abuse (105 studies, 60% of substance 
use exclusions), current drug abuse (109 studies, 63% of substance use exclusions), past alcohol 
abuse (15 studies, 9% of all substance use exclusions), past drug abuse (18 studies, 10% of all 
substance use exclusions), alcohol abuse timeframe not specified (34 studies, 20% of all 
substance use exclusions), and drug abuse timeframe not specified (39 studies, 23% of all 
substance use exclusions). 
Frequency of Years  
We also ran Wilcoxon rank sum tests comparing the years of publication for studies with 
vs. without each exclusion criterion. This test allows us to determine if there is a difference in 
date of publication between studies that did vs. did not use exclusion criteria (see Table 2). In 
total we ran 29 Wilcoxon rank sum tests and found that 9 were statistically significant at the p < 
.05 level. These differences suggest a relation between studies dates of publication and the 
exclusion criteria used.  
As shown in Table 2, use of self-harm, excluding based on a suicide related measure, and 
requiring hospitalization all exhibited significant change over time. The exclusion for requiring 
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hospitalization tended to be used more often in earlier studies with the median year for studies 
using this exclusion being 1996 as compared the median year for studies not using the exclusion 
being 2001. For self-harm and suicide measures, the use of these exclusions was more common 
in recent studies. For self-harm, the median year of studies using the exclusion was 2010 as 
compared with the median year for studies not using the exclusion of 2001. Similarly, for suicide 
measures, the median year of studies using the exclusion was 2005 as compared with the median 
year for studies not using the exclusion of 2001. 
Of the 11 disorder related exclusion variables examined, three showed significant 
changes in frequency over time: none (indicating no disorder-based exclusions), bipolar, and 
ASPD. Both the variable none and ASPD were used significantly more often in earlier studies. 
For none, the median year of studies with the exclusion (i.e., studies that did not exclude based 
on having a disorder other than MDD) was 1998 whereas the median year for the remaining 
studies was 2002. For ASPD, the median year of studies using this exclusion was 1999 and the 
median year for the remaining studies was 2001. Use of the bipolar exclusion was more common 
in recent studies. The median year of studies using a bipolar exclusion was 2002, whereas the 
median year for the remaining studies was 2000.  
Of the seven substance use disorder variables examined, three showed significant 
changes over time: current alcohol abuse, current drug abuse, and past alcohol abuse. Past 
alcohol abuse was excluded more often in earlier studies, with the median year being 1995 for 
studies using this exclusion vs. the median year of 2001 for those not using the exclusion. Both 
current alcohol abuse and current drug abuse were used more often in later years. For both of 
these exclusions, the median year for studies using the exclusions was 2003, whereas the median 
for studies not using the exclusion being 2000.  
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Discussion 
One key finding from this study is that only 16% of all studies with suicide related 
exclusions clearly defined their methods for that exclusion and were coded as using suicide 
measures. The remaining 84% of studies either did not mention suicide as an exclusion or 
inclusion criteria (54%) or contained suicide related exclusions that were described without a 
concrete definition (e.g., suicidal ideation without measure specified or imminent suicidal risk 
without measure specified) (30%), making strict replication of these studies difficult. Although 
many of these studies used the same or similar terminology (suicidal ideation or suicidal risk), it 
is unclear to what extent this may have been interpreted or assessed differently across studies. 
We think it would be a positive step to call on researchers to more clearly and consistently use 
concrete criteria to define any such exclusion criteria in future trials.  
Additionally, the studies that were found to use suicide measures in defining an exclusion 
criterion occurred earlier in our data set, suggesting that in recent years researchers have been 
straying away from clearly defining their terms of exclusion. Outside of the consideration of 
measures to assess suicide related exclusions, we also found greater use of rates of self-harm and 
requiring hospitalization exclusions in more recent studies. To our knowledge, there has been 
little discussion of the value of these specific exclusions. Therefore, it is unclear why these 
changes have occurred.  
We did not find any significant change over time in excluding participants due to 
depression not being primary. This may indicate that there may still be issues within depression 
RCT literature that have not changed between 1975 and 2012. Efforts to identify which disorder 
is primary sometimes consider the order in which the disorders developed, which disorder is 
more severe symptomatically, or which disorder causes greater functional impairment. In any 
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case, these are difficult judgments made largely without the aid of a formal assessment suited to 
the purpose. Because of this, we are not aware of any studies assessing the reliability of 
evaluators’ judgments of which disorder is primary. If whether a diagnosis is primary is 
important to include in study eligibility determinations, we recommend that researchers develop 
formal research tools for this purpose.  
The only significant relation between year of publication and those falling within the 
disorder exclusion category were: none, ASPD, and bipolar. The greater use of no disorder 
related exclusions in earlier years appears to indicate that studies have become more restrictive 
and started to include less individuals with various psychological disorders other than 
depression. ASPD’s higher frequency as an exclusion in earlier years in our data set contradicts 
this pattern, with ASPD being included in more recent depression trials, possibly due to a 
growing consensus surrounding the difficulty of treating ASPD. The increased frequency of 
bipolar disorder exclusions indicates that more recent studies have more consistently restricted 
individuals with bipolar disorder from participating in depression research, this is also likely due 
to a growing recognition of the importance of the distinction between unipolar and bipolar 
disorders.  
Our results also demonstrate that axis I disorders were excluded in 14% of all randomized 
controlled depression trials. Though this percentage does not appear to be large, previous work 
done by Stirman, DeRubeis, Crits-Christoph, and Rothman (2005) indicates that individuals with 
social anxiety disorders who are excluded from RCTs of depression research often do not qualify 
for other studies looking at their comorbidity. Depression and anxiety are highly comorbid. 
Therefore, anxiety disorders exclusions have the potential to greatly limit the information 
provided about whether many patients would benefit from depression treatment. The field could 
EXCLUSION CRITERIA TRENDS   
 
17 
address this by conducting trials focused on specific comorbidities, testing whether focusing one 
disorder or the other is a more promising approach. In the absence of such studies, allowing 
patients with these comorbidities into studies of treatments for depression or anxiety disorders at 
least allows investigators to go back and examine these comorbidities as moderators of treatment 
outcome.  
Next, we turn to our results from the substance use exclusion category. As previous 
research has demonstrated, individuals with substance use disorders excluded from depression 
research were especially likely to be unrepresented elsewhere in the clinical trial literature 
(Stirman, DeRubeis, Crits-Christoph, & Rothman, 2005). We found that 52% of all studies in our 
analysis excluded individuals due to some form of substance use condition. The exclusion of 
such a large number of possible participants demonstrates that much of the previously conducted 
randomized control trials on adult depression may not generalize to a large portion of the 
population of interest. There is a need for trials that address such comorbidity.  
Of the 173 studies that excluded these individuals, 10% excluded individuals with a 
previous history of past drug abuse and 9% excluded individuals with a past history of alcohol 
abuse. This is a sweeping exclusion as these individuals would never be eligible for a study even 
if their substance use disorders were in remission. An additional 20% of alcohol abuse 
exclusions did not specify a timeframe for what qualified a participant for exclusion, with the 
same being true for 23% of all drug abuse exclusions. Open ended exclusion criteria such as this 
leaves much up to the individual readers’ interpretation of the study and makes replicating these 
studies open to error. Research to address what the best treatment options are for such patients is 
needed.  
Limitations 
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Our main limitation comes from the range of studies under review. As we chose to use a 
pre-existing data set to aide us in the task of collecting studies we were limited to analyzing 
studies from 1975-2012. Since the end of our data collection process the data set in question has 
been updated through 2018, nearly doubling the number of studies within it for a total of 662 
(Cuijpers et. al. 2020). In order to give a fully comprehensive review of exclusion criteria trends 
in randomized controlled studies of adult depression, studies from more recent years would need 
to be analyzed.  
Another limitation is related to our inclusion of brief reports. Although we would hope 
that inclusion and exclusion criteria are described no matter how brief a report is, this may not be 
the case. Due to the brevity of brief reports, authors may have met the length restrictions by 
shortening their coverage of inclusion/exclusion criteria. If brief reports under report exclusion 
criteria they used, this would have positively skewed the number of studies that appeared to have 
no exclusion criteria. It is worth noting that the increased usage of clinicaltrials.gov may help to 
address this problem moving forward. This website allows investigators to provide detailed 
inclusion / exclusion criteria and is already seeing widespread adoption.  
Additionally, there are important questions that remain to be addressed with our own data 
set. In future projects, we would like to look into other frequent comorbidity exclusions such as 
eating disorders, which were coded for within our data set. We also plan to examine journal 
impact factors of studies and their relations to use of exclusion criteria.  
Implications  
The results of this study point to some potentially important implications for randomized 
controlled trials of depression psychotherapy trials. To our knowledge, our project is the first to 
take a detailed look at the use of various inclusion and exclusion criteria to date. Future research 
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should continue our work and evaluate more recently published studies on randomized controlled 
studies of adult depression. We encourage researchers to think carefully about how to 
operationalize their exclusion criteria so that our confidence in the use of these criteria across 
trials can be increased. 
Conclusion 
 Between 1975 and 2012 there have been important shifts in the exclusion criteria used in 
randomized clinical trials of psychotherapies for adults with depression. While many of these 
shifts are positive, and demonstrate the fields increased knowledge of MDD, others may be seen 
as problematic for their lack of clear operationalization or their leading to important subgroups of 
patients who are not adequately represented in the treatment outcome literature. We encourage 
researchers to think carefully about the inclusion / exclusion criteria they use, so as to not 
unnecessarily exclude patients who might benefit from a treatment and to use measures of these 
criteria that can be used consistently across trials and in clinical practice.  
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Table 1: Cohen's Kappa's and Variable Frequencies  
Variable  Kappa Frequency  Percentage  
 
Suicide Related Exclusions   
None .91 180 54% 
Suicidal Ideation (without mesure 
specified)  .90 90 27% 
Suicide Risk (without mesure specified) .98 56 17% 
Require Hospitalization .69 10 3% 
Plan .89 13 4% 
Self-Harm 1.00 3 1% 
Past History  .80 18 5% 
Require Previous Ideation .67 3 1% 
Suicide Measures .75 22 15% 
 
Disorder Related Exclusions   
Antisocial Personality Disorder  .92 39 12% 
Any Bipolar Disorder .81 135 41% 
Borderline Personality Disorder .76 25 8% 
Psychosis  .71 163 49% 
Schizotypal .80 17 5% 
Any Personality Disorder .66 11 3% 
Axis I  .94 46 14% 
None .67 99 30% 
 
Depression as Not Primary Exclusions   
Relative to a Specific Diagnosis .80 30 9% 
Diagnosis  .96 126 38% 
Multiple Not Primary Exclusions  .91 40 12% 
Primary/Principal  .91 31 9% 
None  .94 124 37% 
 
Substance Use Exclusions   
None .90 159 48% 
Current Alcohol Abuse  .86 105 32% 
Current Drug Abuse  .84 109 33% 
Past Alcohol Abuse .52 15 5% 
Past Drug Abuse  .53 18 5% 
Alcohol Abuse Not Specified  .70 34 10% 
Drug Abuse Not Specified  .68 39 12% 
 
* Percentage does not equal 100%   
EXCLUSION CRITERIA TRENDS   
 
23 
Table 2. Differences in Year of Publication for Studies that Did not vs. Did Use Exclusion Criteria 
 
 
 Not Excluded  Excluded 
 
 Median Mean Median Mean   
Variable  Year Rank Year Rank Z p 
 
 
Suicide Related Exclusions 
None 2001 171.36 2000 164.19 0.68 .25 
Suicidal Ideation (without measure specified) 2001 173.15 2002 165.45 0.64 .26 
Suicide Risk (without measure specified)  2001 171.09 2000 148.91 -1.55 .06 
Plan 2001 165.97 2005 205.38 1.44 .07 
Self-Harm* 2001 166.58 2010 269.33 1.83 .03 
Past History Exclusion  2001 167.14 2003 173.89 0.29 .39 
Require Previous Ideation  2001 167.75 1998 139.67 -0.50 .31 
Suicide Measures * 2001 165.00 2005 206.68 1.87 .03 
Require Hospitalization * 2001 169.00 1996 118.65 -1.63 .05 
 
Disorder Related Exclusions 
None* 2002 169.11 1998 142.80 -2.35 .01 
Antisocial Personality Disorder* 2001 138.09 1999 164.17 -1.65 .05 
Axis I 2000 160.23 2002 182.73 0.79 .21 
Bipolar* 2000 152.56 2002 172.63 1.91 .03 
Borderline Personality Disorder 2000 161.11 2002 159.68 -0.07 .47 
Cluster A 2001 160.79 2006 193.25 0.49 .31 
Psychosis  2000 154.11 2001 167.68 -1.31 .09 
Schizoaffective 2001 161.35 1998 154.71 -0.29 .39 
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Table 2 (continued) 
 
 
 Not Excluded  Excluded 
 
 Median Mean Median Mean   
Variable  Year Rank Year Rank Z p 
 
 
Depression as Not Primary Exclusions 
None 2000 159.30 2000 162.40 0.29 .39 
Diagnosis 2000 163.20 2001 158.74 0.42 .34 
Multiple Not Primary Exclusions 2000 160.81 2000 158.35 -0.16 .44 
Relative to a Specific Diagnosis 2000 162.19 1999 144.18 -1.02 .15 
 
Substance Use Exclusions 
None 2002 168.86 1999 153.00 -1.53 .06 
Current Alcohol Abuse* 2000 173.57 2003 154.90 1.70 .04 
Current Drug Abuse* 2000 173.60 2003 154.52 1.75 .04 
Past Alcohol Abuse* 2001 162.93 1995 121.57 -1.68 .04 
Past Drug Abuse 2001 162.87 1996 129.47 -1.48 .06 
Alcohol Abuse Not Specified 2000 158.90 2002 178.69 1.17 .12 
Drug Abuse Not Specified  2000 158.63 2002 178.14 1.23 .11 
 
 
 
 
 
  
